Leadership and governance
The Mayo Clinic Robert M. and Billie Kelley Pirnie Translational Polycystic Kidney Disease Center is supported by a robust leadership team of PKD experts, ensuring a strong commitment to research that ultimately improves outcomes for people affected by these conditions.
Steering Committee
The Steering Committee is responsible for the center's overall strategic direction and oversight of all operations.
Members include:
- Peter C. Harris, Ph.D.
- Center Director
- Director, Genetics, Epigenetics and Metabolomics Core
- Neera K. Dahl, M.D., Ph.D.
- Center Associate Director
- Director, PKD Clinical Center of Excellence
- Xiaogang Li, Ph.D.
- Center Associate Director
- Associate Director Genetics, Epigenetics and Metabolomics Core
- Jinghua Hu, Ph.D.
- Director, Model Systems Core
- Timothy L. Kline, Ph.D., M.S.
- Director, Imaging and Analysis Core
- Vicente E. Torres, M.D., Ph.D.
- Principal Investigator, U.S. Department of Defense Congressionally Directed Medical Research Program award for PKD
- Maria V. Irazabal Mira, M.D., Ph.D.
- Associate Director, Genetics, Epigenetics and Metabolomics Core
- Christian Hanna, M.D., M.S.
- Director, PKD Pediatric Clinical Center of Excellence